PlainRecalls

Staq Pharma, Inc.

Compiled from official public sources by the publisher.

6 recalls on record · Latest: Oct 22, 2025

Subscribe to new Staq Pharma, Inc. recalls (RSS)

Agency notice ledger

Federal filing book Staq Pharma, Inc. LIGHT-BOOK · SINGLE-AGENCY

#2,302 of 14,151 · 6 notices · 0.006% archive

  • BOOK 6 notices
  • RANK #2,302 of 14,151
  • SHARE 0.006% archive
  • AGENCY FDA Drug (6)
  • CAT drugs
  • CATS 2 categories
  • LATEST Oct 22, 2025
  • PHOTO Abbott Molecular

Nearest notice-volume peer: Abbott Molecular (0 notice gap)

Staq Pharma, Inc. accounts for about 0.006% of the 104,423-notice archive on 6 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Staq Pharma, Inc.'s standing among 14,151 recalling firms

Staq Pharma, Inc. ranks 2,302nd of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Staq Pharma, Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

6 2302nd of 14151 higher than 11,804 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Staq Pharma, Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Staq Pharma, Inc. holds about 0.006% of archive notices alongside 6 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Low Oct 22, 2025

Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0156-02.
FDA Drug Low Oct 22, 2025

Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.
FDA Drug Low Oct 22, 2025

FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0102-05.
FDA Drug Moderate Dec 13, 2023

ROPivacaine HCl 0.2% PF in Sodium Chloride 1,000 mg/500 mL (2 mg per mL) Injection, 500 mL bags, Rx only, STAQ Pharma Inc. 14135 E 42nd Ave, Unit 50, Denver, Colorado 80239, NDC 73177-0109-26,
FDA Drug Critical Feb 23, 2022

HYDROmorphone HCl PF 10 mg/50 mL (0.2mg/mL) in NaCl, 50 mL in 50 mL Single Dose Syringe, Rx only, STAQ Pharma, Inc., Denver, CO 80239, NDC: 73177-0104-05.
FDA Drug Critical Feb 23, 2022

Morphine Sulfate PF 25 mg/25mL (1 mg/mL) in NaCl, 25 mL in 30 mL Single Dose Syringe, Rx only, STAQ Pharma, Inc., Denver, CO 80239, NDC: 73177-0105-04.

Staq Pharma, Inc. holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (6 here).

Abbott Molecular 6 Accriva Diagnostics, Inc. 6 Advance Medical Designs, Inc. 6 Agave Dream 6 Air Stream Corp. 6

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

Aire-Master of America Inc 6 Apollo Care 6 Appco Pharma LLC 6 Aspen Biopharma Labs Pvt., Ltd. 6

Frequently Asked Questions

How many federal recall notices name Staq Pharma, Inc.? ▼
PlainRecalls indexes 6 distinct federal recall events naming Staq Pharma, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Staq Pharma, Inc. sit among other recalling firms? ▼
Staq Pharma, Inc. ranks #2,302 of 14,151 by distinct recall-event count among 14,151 firms in this archive (83rd percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Staq Pharma, Inc.'s notices? ▼
FDA Drug accounts for 6 of this firm's 6 indexed notices.
What product category dominates Staq Pharma, Inc.'s filing book? ▼
Filings for Staq Pharma, Inc. span 2 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Staq Pharma, Inc.: 6 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Staq Pharma, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026